Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. November 2011 09:00 ET | Quelle: Conceptus, Inc.

Conceptus(R) Announces 10-Year Commercial Data for Essure(R) at 40th AAGL Global Congress of Minimally Invasive Gynecology

MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
07. November 2011 17:15 ET | Quelle: Conceptus, Inc.

Conceptus(R) to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
25. Oktober 2011 16:05 ET | Quelle: Conceptus, Inc.

Conceptus(R) Reports Third Quarter Financial Results

Domestic physician penetration metrics solid Updates 2011 financial guidance MOUNTAIN VIEW, Calif., Oct. 25, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the...
17. Oktober 2011 19:32 ET | Quelle: Conceptus, Inc.

Conceptus(R) Wins Favorable Verdict in Patent Litigation Against Hologic; Jury Awards Conceptus $18.8 Million

MOUNTAIN VIEW, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
04. Oktober 2011 16:16 ET | Quelle: Conceptus, Inc.

Conceptus(R) Acquires All Distribution Rights Related to the Essure(R) Procedure in the Netherlands

MOUNTAIN VIEW, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
04. Oktober 2011 16:15 ET | Quelle: Conceptus, Inc.

Conceptus(R) to Hold Third Quarter Financial Results Conference Call on October 25, 2011

MOUNTAIN VIEW, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
26. August 2011 09:00 ET | Quelle: Conceptus, Inc.

Conceptus(R) Enters Into New Revolving Line of Credit Agreement With Wells Fargo Bank, N.A.

MOUNTAIN VIEW, Calif., Aug. 26, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
24. August 2011 17:30 ET | Quelle: Conceptus, Inc.

Conceptus(R) to Present at the Stifel Nicolaus 2011 Healthcare Conference

MOUNTAIN VIEW, Calif., Aug. 24, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method...
04. August 2011 16:10 ET | Quelle: Conceptus, Inc.

Conceptus(R) Announces FDA Approval to Remove Nickel Contraindication From the Essure Procedure Instructions

MOUNTAIN VIEW, Calif., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the Essure® procedure, the most effective non-surgical permanent birth control method available,...
04. August 2011 16:05 ET | Quelle: Conceptus, Inc.

Conceptus(R) Reports Second Quarter Financial Results

Reports Net Sales of $33.8 Million, 27% Sequential Growth Expands Hysteroscopic Sterilization Market With Strong New-Physician Penetration Metrics Updates Financial...

Vorherige Seite

Nächste Seite